Despite years of progress in reducing healthcare associated infections (HAIs), research from The Leapfrog Group found the average risk of three HAIs - Methicillin-resistant Staphylococc...
Drugs such as baricitinib and anakinra have shown promise in disrupting the malfunctioning immune response that leads to ongoing lung issues in people who contract COVID-19.
University of Utah Health is one of the participating health systems, aiming to compare the effects of ketamine to fentanyl, as the former has fewer associated risks.